Novocure (NVCR) Tops Q4 EPS by 19c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Join SI Premium – FREE
Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.22), $0.19 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $174.35 million versus the consensus estimate of $168.31 million.
GUIDANCE:
Novocure sees FY2026 revenue of $675-705 million, versus the consensus of $681.2 million.
For earnings history and earnings-related data on Novocure (NVCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- JPMorgan Downgrades Ultrapar Participacoes SA (UGPA3:BZ) (UGP) to Neutral
- Nomura/Instinet Starts National Aluminium (NACL:IN) at Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
